v3.26.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows from Operating Activities:    
Net Loss $ (21,976) $ (13,222)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 31,002 37,025
Deferred financing costs amortization 128 0
Stock-based compensation expense 3,644 4,696
Debt discount amortization 711 694
Allowance for credit losses (5) 7
Gains from equipment sales, retirements or impairments, net (38,791) (55,202)
Derivative gains 0 (229)
Interest on finance leases 3 3
Settlement on derivative transactions, net 0 (373)
Currency losses 302 3,097
Deferred income taxes (1,201) (1,428)
Equity earnings (52) (1,500)
Dividends received from 50% or less owned companies 2,027 3,199
Changes in Operating Assets and Liabilities:    
Accounts receivables (5,017) (1,083)
Other assets (400) 1,605
Accounts payable and accrued liabilities (1,831) (1,491)
Net cash used in operating activities (31,456) (24,202)
Cash Flows from Investing Activities:    
Purchases of property and equipment (19,593) (40,356)
Proceeds from disposition of property and equipment 57,716 116,132
Net cash provided by investing activities 38,123 75,776
Cash Flows from Financing Activities:    
Payments on long-term debt (22,500) (20,000)
Proceeds from issuance of long-term debt, net of debt discount and issuance costs 0 15,799
Payments on finance leases (15) (16)
Payments for repurchase of common stock 0 (7,089)
Payments for repurchase of warrants 0 (6,668)
Excise tax on stock repurchase 22 0
Proceeds from exercise of stock options 80 0
Tax withholdings on restricted stock vesting and director share awards (1,779) (1,529)
Net cash used in financing activities (24,192) (19,503)
Effects of Exchange Rate Changes on Cash, Restricted Cash and Cash Equivalents (1) (3)
Net Change in Cash, Restricted Cash and Cash Equivalents (17,526) 32,068
Cash, Restricted Cash and Cash Equivalents, Beginning of Period 93,116 76,140
Cash, Restricted Cash and Cash Equivalents, End of Period 75,590 108,208
Supplemental disclosures:    
Cash paid for interest, excluding capitalized interest 23,225 26,683
Income taxes refunded, net 102 1,095
Noncash Investing and Financing Activities:    
Increase (decrease) in capital expenditures in accounts payable and accrued liabilities 267 (5,377)
Recognition of a new right-of-use asset - operating leases 230 0
Recognition of a new right-of-use asset - finance leases $ 95 $ 0